Sweden Faces Delays For Rare Disease Medicines
Swedish patients with rare diseases are experiencing extended wait times for new medicines, with an average availability time exceeding 21 months. The time to availability has risen significantly.
Topics
Developing
- 882d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 882d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 882d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 882d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
Mastodon
“Swedish rare disease patients endure longer wait for new medicines [Advocacy Lab]: It takes more than 21 months for a new orphan drug to reach Sweden, the average time to availability has risen by 153...”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade